Cargando…

The effect of hypothalamic involvement and growth hormone treatment on cardiovascular risk factors during the transition period in patients with childhood-onset craniopharyngioma

PURPOSE: Hypothalamic damage may increase the risk of adulthood obesity and cardiovascular disease in patients with craniopharyngioma. We evaluated the effects of hypothalamic involvement (HI) and growth hormone (GH) discontinuation on cardiovascular risk factors during the transition period in pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Sang Hee, Lee, Yun Jeong, Cheon, Jung-Eun, Shin, Choong Ho, Jung, Hae Woon, Lee, Young Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Pediatric Endocrinology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329945/ https://www.ncbi.nlm.nih.gov/pubmed/35798299 http://dx.doi.org/10.6065/apem.2244046.023

Ejemplares similares

The Effect of Hypothalamic Involvement and Growth Hormone Treatment on Cardiovascular Risk Factors in Patients With Childhood-Onset Craniopharyngioma
por: Park, Sang Hee, et al.
Publicado: (2021)

Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma
por: Jung, Hae Woon, et al.
Publicado: (2021)

Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma
por: Park, Seung Wan, et al.
Publicado: (2013)

Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma
por: Miao, Yuqi, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma
por: Jung, So Yoon, et al.
Publicado: (2017)

Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency
por: Lee, Yun Jeong, et al.
Publicado: (2022)

Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood‐onset craniopharyngioma
por: Fjalldal, Sigridur, et al.
Publicado: (2020)

Increased Daytime Sleepiness in Patients with Childhood Craniopharyngioma and Hypothalamic Tumor Involvement: Review of the Literature and Perspectives
por: Müller, Hermann L.
Publicado: (2010)

Hypothalamic glioma masquerading as craniopharyngioma
por: Vyas, Sameer, et al.
Publicado: (2013)

Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higher homeostasis model insulin resistance index
por: Trivin, Christine, et al.
Publicado: (2009)

MON-456 Determinants of Hypothalamic Obesity Following Surgical Treatment for Craniopharyngioma in Adults
por: Hong, A Ram, et al.
Publicado: (2019)

SAT-461 Long-Term Effects of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (Hit-Endo)
por: Boekhoff, Svenja, et al.
Publicado: (2019)

MON-443 Periostin Concentrations in Childhood-Onset Craniopharyngioma Patients
por: Heinks, Kerstin, et al.
Publicado: (2019)

Vision-related quality of life in patients with childhood-onset craniopharyngioma
por: Sowithayasakul, Panjarat, et al.
Publicado: (2023)

Hypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and Treatment
por: Lustig, Robert H.
Publicado: (2011)

MON-LB45 Posterior Hypothalamic Involvement on Pre-Operative Magnetic Resonance Imaging as a Predictor for Hypothalamic Obesity in Craniopharyngiomas
por: Rachmasari, Kharisa N, et al.
Publicado: (2020)

Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases
por: Wu, Wei, et al.
Publicado: (2021)

Cerebral Infarction in Childhood-Onset Craniopharyngioma Patients - Results of KRANIOPHARYNGEOM 2007
por: Boekhoff, Svenja, et al.
Publicado: (2021)

Cerebral Infarction in Childhood-Onset Craniopharyngioma Patients: Results of KRANIOPHARYNGEOM 2007
por: Boekhoff, Svenja, et al.
Publicado: (2021)

LTBK-02. Safety of growth hormone replacement therapy in childhood craniopharyngioma
por: van Schaik, Jiska, et al.
Publicado: (2022)

Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma
por: Guo, Ying, et al.
Publicado: (2023)

Treatment Strategies in Childhood Craniopharyngioma
por: Puget, Stéphanie
Publicado: (2012)

Surgical Strategies in Childhood Craniopharyngioma
por: Flitsch, Jörg, et al.
Publicado: (2011)

Aggressive Childhood-onset Papillary Craniopharyngioma Managed With Vemurafenib, a BRAF Inhibitor
por: Chik, Constance L, et al.
Publicado: (2021)

Early Treatment of Hypothalamic Hypogonadism With LH-RH Analog Improved the Long-Term Prognosis of Hypogonadism of Adult-Onset Craniopharyngioma
por: Iwabuchi, Masayasu
Publicado: (2021)

Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity
por: Müller, Hermann L.
Publicado: (2016)

Hypothalamic Injury Following Surgery for Craniopharyngioma Causing Immediate Postoperative Death
por: Bhandari, Pooja, et al.
Publicado: (2021)

Endoscopic endonasal resection of giant pediatric craniopharyngioma: impact on hypothalamic edema
por: Gerges, Mina M., et al.
Publicado: (2020)

RARE-01. Cerebral infarction in childhood-onset craniopharyngioma patients: results of KRANIOPHARYNGEOM 2007
por: Boekhoff, Svenja, et al.
Publicado: (2022)

THU216 The Influence Of Age At Diagnosis On Clinical Presentation And Prognosis Of Childhood-onset Craniopharyngioma
por: Beckhaus, Julia, et al.
Publicado: (2023)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
por: Lim, Han Hyuk, et al.
Publicado: (2010)

Intracystic Therapies for Cystic Craniopharyngioma in Childhood
por: Bartels, Ute, et al.
Publicado: (2012)

Hypothalamic Obesity in Patients with Craniopharyngioma: Profound Changes of Several Weight Regulatory Circuits
por: Roth, Christian L.
Publicado: (2011)

A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
por: Craven, Meghan, et al.
Publicado: (2022)

Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention
por: Roth, Christian L.
Publicado: (2015)

SUN-289 Childhood-Onset, Adamantinomatous Craniopharyngioma and Successful Pregnancy: Results of Kraniopharyngeom 2000/2007
por: Sowithayasakul, Panjarat, et al.
Publicado: (2020)

Cardiac remodeling in patients with childhood-onset craniopharyngioma—results of HIT-Endo and KRANIOPHARYNGEOM 2000/2007
por: Sowithayasakul, Panjarat, et al.
Publicado: (2021)

Cardiac Remodeling in Patients with Childhood-Onset Craniopharyngioma - Results of HIT-Endo and KRANIOPHARYNGEOM 2000/2007
por: Sowithayasakul, Panjarat, et al.
Publicado: (2021)

Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report
por: Jung, Dai, et al.
Publicado: (2018)

Hormonal regulation of the hypothalamic melanocortin system
por: Kim, Jung D., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6dpeohspo11ralplcpaslrhnp2